Evidence map›Paper›PMID 36733641›Full record

ArticleThe Canadian veterinary journal = La revue veterinaire canadienne2023

Prognostic indicators in dogs with intra-hepatic portal hypertension.

Shaun Calleja, Robert Shiel, Laura Bree, Paolo Silvestrini, Mary Trehy, Lucy McMahon, Kevin Murtagh

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in The Canadian veterinary journal = La revue veterinaire canadienne, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shaun CallejaLumbry Park Veterinary Specialists, Alton, UK (Calleja); Murdoch University, Perth, Western Australia (Shiel); Willows Veterinary Centre and Referral Service, Solihull, UK (Bree); Ryan Veterinary Hospital - PennVet, University of Pennsylvania, Philadelphia, Pennsylvania, USA (Silvestrini); North Downs Specialist Referrals, Bletchingley, UK (Trehy); Anderson Moores Veterinary Specialists, Winchester, UK (McMahon); University College Dublin, School of Veterinary Medicine, Dublin, Ireland (Murtagh).
Robert ShielLumbry Park Veterinary Specialists, Alton, UK (Calleja); Murdoch University, Perth, Western Australia (Shiel); Willows Veterinary Centre and Referral Service, Solihull, UK (Bree); Ryan Veterinary Hospital - PennVet, University of Pennsylvania, Philadelphia, Pennsylvania, USA (Silvestrini); North Downs Specialist Referrals, Bletchingley, UK (Trehy); Anderson Moores Veterinary Specialists, Winchester, UK (McMahon); University College Dublin, School of Veterinary Medicine, Dublin, Ireland (Murtagh).
Laura BreeLumbry Park Veterinary Specialists, Alton, UK (Calleja); Murdoch University, Perth, Western Australia (Shiel); Willows Veterinary Centre and Referral Service, Solihull, UK (Bree); Ryan Veterinary Hospital - PennVet, University of Pennsylvania, Philadelphia, Pennsylvania, USA (Silvestrini); North Downs Specialist Referrals, Bletchingley, UK (Trehy); Anderson Moores Veterinary Specialists, Winchester, UK (McMahon); University College Dublin, School of Veterinary Medicine, Dublin, Ireland (Murtagh).
Paolo SilvestriniLumbry Park Veterinary Specialists, Alton, UK (Calleja); Murdoch University, Perth, Western Australia (Shiel); Willows Veterinary Centre and Referral Service, Solihull, UK (Bree); Ryan Veterinary Hospital - PennVet, University of Pennsylvania, Philadelphia, Pennsylvania, USA (Silvestrini); North Downs Specialist Referrals, Bletchingley, UK (Trehy); Anderson Moores Veterinary Specialists, Winchester, UK (McMahon); University College Dublin, School of Veterinary Medicine, Dublin, Ireland (Murtagh).
Mary TrehyLumbry Park Veterinary Specialists, Alton, UK (Calleja); Murdoch University, Perth, Western Australia (Shiel); Willows Veterinary Centre and Referral Service, Solihull, UK (Bree); Ryan Veterinary Hospital - PennVet, University of Pennsylvania, Philadelphia, Pennsylvania, USA (Silvestrini); North Downs Specialist Referrals, Bletchingley, UK (Trehy); Anderson Moores Veterinary Specialists, Winchester, UK (McMahon); University College Dublin, School of Veterinary Medicine, Dublin, Ireland (Murtagh).
Lucy McMahonLumbry Park Veterinary Specialists, Alton, UK (Calleja); Murdoch University, Perth, Western Australia (Shiel); Willows Veterinary Centre and Referral Service, Solihull, UK (Bree); Ryan Veterinary Hospital - PennVet, University of Pennsylvania, Philadelphia, Pennsylvania, USA (Silvestrini); North Downs Specialist Referrals, Bletchingley, UK (Trehy); Anderson Moores Veterinary Specialists, Winchester, UK (McMahon); University College Dublin, School of Veterinary Medicine, Dublin, Ireland (Murtagh).
Kevin MurtaghLumbry Park Veterinary Specialists, Alton, UK (Calleja); Murdoch University, Perth, Western Australia (Shiel); Willows Veterinary Centre and Referral Service, Solihull, UK (Bree); Ryan Veterinary Hospital - PennVet, University of Pennsylvania, Philadelphia, Pennsylvania, USA (Silvestrini); North Downs Specialist Referrals, Bletchingley, UK (Trehy); Anderson Moores Veterinary Specialists, Winchester, UK (McMahon); University College Dublin, School of Veterinary Medicine, Dublin, Ireland (Murtagh).
Willows Veterinary Centre and Referral Service · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: The primary goals of this retrospective study were to describe a population of dogs with portal hypertension secondary to liver disease, and to assess whether prognosis could be inferred from historical, clinical, and clinicopathological data. Animals and procedures: Dogs (N = 76) diagnosed with intrahepatic portal hypertension between 2011 and 2020 were included; dogs with known congenital hepatic anomalies were excluded. Effect on survival was assessed using univariable and multivariable Cox proportional hazards models for historical, clinical, and clinicopathological variables. Results: Dogs survived for a median of 14 d (range: 0 to 2028 d), with 31.6% being euthanized within 2 d of diagnosis and 23.7% surviving longer than 2 mo. Presence of jaundice and duration of clinical signs, expressed in days, were significantly associated with outcome in the univariable analysis (HR = 1.846, 95% CI: 1.094 to 3.117, Conclusion: Results of this study show that portal hypertension is associated with a poor prognosis; however, some dogs can show prolonged survival. Clinical relevance: Clinical data can guide decision-making for clinicians and owners.

Indexed as

Dog DiseasesHypertension, PortalAnimalsDogsPrognosisRetrospective Studies

Identifiers

PMID36733641
PMCPMC9847403
OpenAlexW4319061321

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.